These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21180666)

  • 21. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic and therapeutic strategies in treatment-resistant depression. Switching antidepressants vs. conventional augmentation strategies.
    Papakostas GI
    CNS Spectr; 2009 Mar; 14(3 Suppl 4):11-4. PubMed ID: 19407715
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis and treatment of a major depressive episode.
    Thase ME
    J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
    Uchida H; Suzuki T; Watanabe K; Kashima H
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):126. PubMed ID: 19154222
    [No Abstract]   [Full Text] [Related]  

  • 25. How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
    Preskorn SH
    J Psychiatr Pract; 2008 May; 14(3):170-5. PubMed ID: 18520787
    [No Abstract]   [Full Text] [Related]  

  • 26. When should you move beyond first-line therapy for depression?
    McIntyre RS
    J Clin Psychiatry; 2010; 71 Suppl 1():16-20. PubMed ID: 20977871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
    Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
    J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations.
    Mohamed S; Johnson GR; Vertrees JE; Guarino PD; Weingart K; Young IT; Yoon J; Gleason TC; Kirkwood KA; Kilbourne AM; Gerrity M; Marder S; Biswas K; Hicks P; Davis LL; Chen P; Kelada A; Huang GD; Lawrence DD; LeGwin M; Zisook S
    Psychiatry Res; 2015 Oct; 229(3):760-70. PubMed ID: 26279130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for switching antidepressants to achieve maximum efficacy adolescents.
    Jefferson JW
    J Clin Psychiatry; 2008; 69 Suppl E1():14-8. PubMed ID: 18494539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antidepressive agents in the elderly].
    de Hooge JK
    Tijdschr Gerontol Geriatr; 1990 Dec; 21(6):259-67. PubMed ID: 1980385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants in bipolar depression: when less is more.
    Ruzickova M; Alda M
    J Psychiatry Neurosci; 2002 Jul; 27(4):312. PubMed ID: 12174738
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 34. Open trials in psychiatry: comments on article by Uchida et Al.
    Magalhães PV
    J Clin Psychopharmacol; 2007 Jun; 27(3):318; author reply 318-9. PubMed ID: 17502793
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on partial response in depression.
    Thase ME
    J Clin Psychiatry; 2009; 70 Suppl 6():4-9. PubMed ID: 19922738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major depressive disorder treatment guidelines in China.
    Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e06. PubMed ID: 20371033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
    Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
    Windhagen A; Wurster U; Kropp S; Ziegenbein M
    Aust N Z J Psychiatry; 2006; 40(11-12):1039-41. PubMed ID: 17054574
    [No Abstract]   [Full Text] [Related]  

  • 39. Algorithms in clinical psychiatry: a stepped approach toward the path to recovery.
    Trivedi M
    Psychopharmacol Bull; 2002; 36 Suppl 2():142-9. PubMed ID: 12490830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.
    Presecki P; Mihanović M; Silić A; Vuina AL; Caratan S
    Psychiatr Danub; 2010 Jun; 22(2):360-2. PubMed ID: 20562783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.